Wang S-M, Wu H-E, Yasui Y, Geva M, Hayden M, Maurice T, et al
Research overview Related protocols and comparisons BPC-157 (5 mg Vial) Dosage Protocol BPC-157 (10 mg Vial) Dosage Protocol BPC-157 + TB-500 (20 mg Blend) Dosage Protocol TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol Tri-Heal (45 mg Blend) Dosage Protocol GLOW (70 mg Blend) Dosage Protocol KLOW (80 mg Blend) Dosage Protocol TB-500 (5 mg Vial) Dosage Protocol
Fisher GJ, Kang S, Varani J, et al
Compounded preparations are dispensed by a licensed 503A pharmacy pursuant to a prescription based on documented clinical need
The gastrointestinal side effect burden could be substantial, given that CagriSema already produces higher nausea rates than either component alone